Given the data above in bone and cancer, HOXC-AS3 upregulation appears to be pro-growth and linked with expression of HOXC10, therefore their increase in the current study maybe hypothesised to be a co-operative and compensatory drive to maintain aged muscle. The gene discussed is HOXC10; the disease is cancer.